Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence

Pathogens and Global Health

Volumn 111, Issue 2, 2017, Pages 59-68

  Mipatrini, Daniele ^a   Stefanelli, Paola ^b   Severoni, Santino ^c   Rezza, Giovanni ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

Author keywords

diphteria; Europe; hepatitis; measles; meningitis; Migration; mumps; pertussis; poliomyelitis; refugees; rubella; tetanus; vaccination; varicella

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; TETANUS TOXOID;

ARTICLE; BIBLIOGRAPHIC DATABASE; BIOLOGICAL ACCIDENT; CHICKENPOX; COUNTRY ECONOMIC STATUS; DIPHTHERIA; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEPATITIS B; HUMAN; IMMUNITY; MEASLES; MEDICOLEGAL ASPECT; MENINGITIS; MIGRANT; MULTIPLE DRUG DOSE; MUMPS; NONHUMAN; PERTUSSIS; POLIOMYELITIS; PREVALENCE; PREVENTIVE HEALTH SERVICE; REFUGEE; RUBELLA; SYSTEMATIC REVIEW; TETANUS; VACCINATION; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; EUROPE; MIGRATION; PROCEDURES; STATISTICS AND NUMERICAL DATA; UTILIZATION;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; REFUGEES; TRANSIENTS AND MIGRANTS; VACCINATION;

EID: 85011655220     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1080/20477724.2017.1281374     Document Type: Article

References (76)

1. Asylum statistics–statistics explained [Internet]. [cited 2016 Nov 23]. Available from:http://ec.europa.eu/eurostat/statistics-explained/index.php/Asylum_statistics#Decisions_on_asylum_applications.
2. (UNHCR) UNHC for R. UNHCR refugees/migrants emergency response–mediterranean [Internet]. UNHCR Refug Emerg Response–Mediterr. [cited 2016 Nov 23]. Available from:http://data.unhcr.org/mediterranean/regional.php.
3. Migration and health:key issues [Internet]. 2016. [cited 2016 Mar 7]. Available from:http://www.euro.who.int/en/health-topics/health-determinants/migration-and-health/migrant-health-in-the-european-region/migration-and-health-key-issues#292115.
4. Eichner M, Brockmann SO. Polio emergence in Syria and Israel endangers Europe. Lancet. 2013;382:1777.10.1016/S0140-6736(13)62220-5
5. PRISMA [Internet]. [cited 2015 Jun 9]. Available from:http://www.prisma-statement.org/statement.htm
6. Grabmeier-Pfistershammer K, Herkner H, Touzeau-Roemer V, et al. Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria. Vaccine. 2015;33:3929–3932.
7. Mullaert J, Abgrall S, Lele N, et al. Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study. Vaccine. 2015;33:4938–4944.10.1016/j.vaccine.2015.07.036
8. Sane J, Sorvari T, Widerstrom M, et al. Respiratory diphtheria in an asylum seeker from Afghanistan arriving to Finland via Sweden, December 2015. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2016;21(2):14–17.
9. Hahné SJM, Veldhuijzen IK, Wiessing L, et al. Infection with hepatitis B and C virus in Europe:a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013;13:181.10.1186/1471-2334-13-181
10. Mockenhaupt FP, Barbre KA, Jensenius M, et al. Profile of illness in Syrian refugees:a geosentinel analysis, 2013 to 2015. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2016;21(10):1–5.
11. Sharma S, Carballo M, Feld JJ, et al. Immigration and viral hepatitis. J Hepatol. 2015;63:515–522.10.1016/j.jhep.2015.04.026
12. Cai W, Poethko-Müller C, Hamouda O, et al. Hepatitis B virus infections among children and adolescents in Germany:migration background as a risk factor in a low seroprevalence population. Pediatr Infect Dis J. 2011;30:19–24.10.1097/INF.0b013e3181ef22d5
13. Mikolajczyk RT, Akmatov MK, Stich H, et al. Association between acculturation and childhood vaccination coverage in migrant populations:a population based study from a rural region in Bavaria, Germany. Int J Public Health. 2008;53:180–187.10.1007/s00038-008-8002-4
14. Ott JJ, Paltiel AM, Winkler V, et al. Chronic disease mortality associated with infectious agents:a comparative cohort study of migrants from the Former Soviet Union in Israel and Germany. BMC Public Health. 2008;8:110.10.1186/1471-2458-8-110
15. Coppola N, Alessio L, Gualdieri L,. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013. Eurosurveillance [Internet] 2015 [cited 2016 May 13];20. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21235.
16. El-Hamad I, Pezzoli MC, Chiari E, et al. Point‐of‐care screening, prevalence, and risk factors for hepatitis B infection among 3728 mainly undocumented migrants from Non‐EU countries in Northern Italy. J Travel Med. 2015;22:78–86.10.1111/jtm.12176
17. Fasano M, Saracino A, Carosi G, et al. Hepatitis B and immigrants:a SIMIT multicenter cross-sectional study. Infection. 2013;41:53–59.10.1007/s15010-012-0384-9
18. Tafuri S, Prato R, Martinelli D, et al. Prevalence of hepatitis B, C, HIV and syphilis markers among refugees in Bari, Italy. BMC Infect Dis. 2010;10:21.10.1186/1471-2334-10-213
19. Villano U, Lo Presti A, Equestre M, et al. Molecular epidemiology and phylogenetic analysis of hepatitis B virus in a group of migrants in Italy. BMC Infect Dis. 2015;15:287.10.1186/s12879-015-0994-9
20. Padovese V, Egidi AM, Melillo TF, et al. Prevalence of latent tuberculosis, syphilis, hepatitis B and C among asylum seekers in Malta. J Public Health Oxf Engl. 2014;36:22–27.10.1093/pubmed/fdt036
21. Hahné SJM, De Melker HE, Kretzschmar M, et al. Prevalence of hepatitis B virus infection in the Netherlands in 1996 and 2007. Epidemiol Infect. 2012;140:1469–1480.10.1017/S095026881100224X
22. Marschall T, Kretzschmar M, Mangen M-JJ, et al. High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. Eur J Gastroenterol Hepatol. 2008;20:1214–1225.10.1097/MEG.0b013e32830e289e
23. Richter C, Ter Beest G, Gisolf EH, et al. Screening for chronic hepatitis B and C in migrants from Afghanistan, Iran, Iraq, the former soviet republics, and Vietnam in the Arnhem region, the Netherlands. Epidemiol Infect. 2014;142:2140–2146.10.1017/S0950268813003415
24. Veldhuijzen IK, van Driel HF, Vos D, de Zwart O, van Doornum GJJ, de Man RA, et al. Viral hepatitis in a multi-ethnic neighborhood in the Netherlands:results of a community-based study in a low prevalence country. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2009;13:e9–13.
25. Veldhuijzen IK, Wolter R, Rijckborst V, et al. Identification and treatment of chronic hepatitis B in Chinese migrants:results of a project offering on-site testing in Rotterdam, the Netherlands. J Hepatol. 2012;57:1171–1176.10.1016/j.jhep.2012.07.036
26. Whelan J, Sonder G, Heuker J, et al. Incidence of acute hepatitis B in different ethnic groups in a low-endemic country, 1992–2009:increased risk in second generation migrants. Vaccine. 2012;30:5651–5655.10.1016/j.vaccine.2012.06.080
27. Zuure FR, Bouman J, Martens M, et al. Screening for hepatitis B and C in first-generation Egyptian migrants living in the Netherlands. Liver Int Off J Int Assoc Study Liver. 2013;33:727–738.10.1111/liv.12131
28. Chu JJ, Wormann T, Popp J, et al. Changing epidemiology of hepatitis B and migration–a comparison of six northern and north-western European countries. Eur J Public Health. 2013;23:642–647.10.1093/eurpub/cks067
29. Tavora-Tavira L, Teodosio R, Seixas J, et al. Sexually transmitted infections in an African migrant population in Portugal:a base-line study. J Infect Dev Ctries. 2007;1:326–328.
30. Monge-Maillo B, Lopez-Velez R, Norman FF, et al. Screening of imported infectious diseases among asymptomatic sub-Saharan African and Latin American immigrants:a public health challenge. Am J Trop Med Hyg. 2015;92:848–856.10.4269/ajtmh.14-0520
31. Chadwick D, Doyle T, Ellis S, Price D, et al. Occult hepatitis B virus coinfection in HIV-positive African migrants to the UK:a point prevalence study. HIV Med. 2014;15:189–192.10.1111/hiv.12093
32. Clark RC, Mytton J. Estimating infectious disease in UK asylum seekers and refugees:a systematic review of prevalence studies. J Public Health Oxf Engl. 2007;29:420–428.10.1093/pubmed/fdm063
33. Cochrane A, Evlampidou I, Irish C, et al. Hepatitis B infection prevalence by country of birth in migrant populations in a large UK city. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2015;68:79–82.10.1016/j.jcv.2015.05.009
34. Hargreaves S, Seedat F, Car J, et al. Screening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK:a cross-sectional study. BMC Infect Dis. 2014;14:657.10.1186/s12879-014-0657-2
35. Uddin G, Shoeb D, Solaiman S, et al. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England:the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat. 2010;17:327–335.10.1111/jvh.2010.17.issue-5
36. Vedio AB, Ellam H, Rayner F, et al. Hepatitis B:report of prevalence and access to healthcare among Chinese residents in Sheffield UK. J Infect Public Health. 2013;6:448–455.10.1016/j.jiph.2013.05.004
37. Rossi C, Shrier I, Marshall L, et al. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees:a systematic review and meta-analysis. PLoS ONE. 2012;7:e44611.10.1371/journal.pone.0044611
38. Williams GA, Bacci S, Shadwick R, et al. Measles among migrants in the European union and the European economic area. Scand J Public Health. 2016;44:6–13.10.1177/1403494815610182
39. Jones G, Haeghebaert S, Merlin B, et al. Measles outbreak in a refugee settlement in Calais, France:January to February 2016. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2016;21:30167.
40. Jablonka A, Happle C, Grote U, et al. Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015. Infection. 2016:1–7.
41. Poethko-Müller C, Ellert U, Kuhnert R, et al. Vaccination coverage against measles in German-born and foreign-born children and identification of unvaccinated subgroups in Germany. Vaccine. 2009;27:2563–2569.10.1016/j.vaccine.2009.02.009
42. Takla A, Barth A, Siedler A, et al. Measles outbreak in an asylum-seekers’ shelter in Germany:comparison of the implemented with a hypothetical containment strategy. Epidemiol Infect. 2012;140:1589–1598.10.1017/S0950268811002597
43. Getaz L, Rieder J-P, Siegrist C-A, et al. Improvement of measles immunity among migrant populations:lessons learned from a prevalence study in a Swiss prison. SwissMedWkly. 2011;141:w13215.
44. Stefanelli P, Fazio C, Neri A, et al. Imported and indigenous cases of invasive meningocococcal disease W:P1.5,2:F1-1:ST-11 in migrants’ reception centers. Italy, June–November 2014. Adv Exp Med Biol. 2016;897:81–83.
45. Tafuri S, Prato R, Martinelli D, et al. Prevalence of carriers of Neisseria meningitidis among migrants:is migration changing the pattern of circulating meningococci? J Travel Med. 2012;19:311–313.10.1111/j.1708-8305.2012.00630.x
46. Tezer H, Ozkaya-Parlakay A, Kanik-Yuksek S, et al. A Syrian patient diagnosed with meningococcal meningitis serogroup B. Hum Vaccines Immunother. 2014;10(8):2482.10.4161/hv.28951
47. Mateen FJ, Carone M, Haskew C, et al. Reportable neurologic diseases in refugee camps in 19 countries. Neurology. 2012;79:937–940.10.1212/WNL.0b013e318266fcf1
48. Hives-Wood S. Syrian refugees could bring polio to Europe, experts warn. BMJ. 2013;347:f6778.10.1136/bmj.f6778
49. Mohammadi D. Middle eastern countries scramble to stop spread of polio. Lancet Lond Engl. 2013;382:1621–1622.10.1016/S0140-6736(13)62289-8
50. Böttcher S, Neubauer K, Baillot A, et al. Stool screening of Syrian refugees and asylum seekers in Germany, 2013/2014:identification of Sabin like polioviruses. Int J Med Microbiol IJMM. 2015;305:601–606.10.1016/j.ijmm.2015.08.008
51. Tafuri S, Prato R, Martinelli D, et al. Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy). BMC Infect Dis. 2008;8:150.10.1186/1471-2334-8-150
52. Tafuri S, Martinelli D, Melpignano L, et al. High level immunity against poliomyelitis in African and Asian refugees in southern Italy. J Travel Med. 2010;17:203–205.10.1111/j.1708-8305.2009.00392.x
53. Tafuri S, Prato R. Re:immunity against poliomyelitis in refugees in Italy. J Travel Med. 2010;17:360–361.
54. Tafuri S, Chironna M, Martinelli D, et al. Surveillance of poliovirus circulation among refugees in Italy, 2008–2011. J Travel Med. 2012;19:61–63.10.1111/j.1708-8305.2011.00571.x
55. Kakoulidou M, Forsgren M, Lewensohn-Fuchs I, et al. Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes. Vaccine. 2010;28:1002–1007.10.1016/j.vaccine.2009.10.130
56. Hardelid P, Cortina-Borja M, Williams D, et al. Rubella seroprevalence in pregnant women in north Thames:estimates based on newborn screening samples. J Med Screen. 2009;16:1–6.10.1258/jms.2009.008080
57. Rapisarda V, Bracci M, Nunnari G, et al. Tetanus immunity in construction workers in Italy. Occup Med Oxf Engl. 2014;64:217–219.
58. Tabibi R, Baccalini R, Barassi A, et al. Occupational exposure to zoonotic agents among agricultural workers in Lombardy region, northern Italy. Ann Agric Environ Med AAEM. 2013;20:676–681.
59. Steens A, Mollema L, Berbers GAM, et al. High tetanus antitoxin antibody concentrations in the Netherlands:a seroepidemiological study. Vaccine. 2010;28:7803–7809.10.1016/j.vaccine.2010.09.036
60. de la Fuente IG, Wagner N, Siegrist C-A, et al. Tetanus immunity as a surrogate for past diphtheria-tetanus-pertussis immunization in migrant children. Pediatr Infect Dis J. 2013;32:274–277.
61. de Valliere S, Cani N, Grossenbacher M, et al. Comparison of two strategies to prevent varicella outbreaks in housing facilities for asylum seekers. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2011;15:e716–21.
62. Gétaz L, Siegrist C-A, Stoll B, et al. Chickenpox in a Swiss prison:susceptibility, post-exposure vaccination and control measures. Scand J Infect Dis. 2010;42:936–940.10.3109/00365548.2010.511259
63. UNICEF CEE/CIS–Media centre–The Lancet:Ukraine at risk of polio outbreak [Internet]. [cited 2016 May 14]. Available from:http://www.unicef.org/ceecis/media_24342.html.
64. Polio in Ukraine–Alert–Level 2, Practice Enhanced Precautions–Travel Health Notices | Travelers’ Health | CDC [Internet]. [cited 2016 May 14]. Available from:http://wwwnc.cdc.gov/travel/notices/alert/polio-ukraine.
65. Eurostat. Countries of origin of (non-EU) asylum seekers in the EU-28 Member States, 2014 and 2015 (thousands of first time applicants) [Internet]. Available from:http://ec.europa.eu/eurostat/statistics-explained/index.php/File:Countries_of_origin_of_(non-EU)_asylum_seekers_in_the_EU-28_Member_States,_2014_and_2015_(thousands_of_first_time_applicants)_YB16.png.
66. Lam E, McCarthy A, Brennan M. Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations. Hum Vaccines Immunother. 2015;11:2627–2636.10.1080/21645515.2015.1096457
67. WHO-UNHCR-UNICEF joint technical guidance:general principles of vaccination of refugees, asylum-seekers and migrants in the WHO European Region [Internet]. 2016 [cited 2016 May 12]. Available from:http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/news/news/2015/11/who,-unicef-and-unhcr-call-for-equitable-access-to-vaccines-for-refugees-and-migrants/who-unhcr-unicef-joint-technical-guidance-general-principles-of-vaccination-of-refugees,-asylum-seekers-and-migrants-in-the-who-european-region
68. Hatzakis A, Wait S, Bruix J, Buti et al. The state of hepatitis B and C in Europe:report from the hepatitis B and C summit conference*. J Viral Hepat. 2011;18:1–16.10.1111/j.1365-2893.2011.01499.x
69. Hatzakis A, Van Damme P, Alcorn K, et al. The state of hepatitis B and C in the mediterranean and Balkan countries:report from a summit conference. J Viral Hepat. 2013;20 Suppl 2:1–20.10.1111/jvh.2013.20.issue-s2
70. Seedat F, Hargreaves S, Friedland JS. Engaging new migrants in infectious disease screening:a qualitative semi-structured interview study of UK migrant community health-care leads. PLoS ONE. 2014;9:e108261.10.1371/journal.pone.0108261
71. Riccardo F, Napoli C, Bella A, Rizzo et al. Syndromic surveillance of epidemic-prone diseases in response to an influx of migrants from North Africa to Italy, May to October 2011. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 2011;16(46):1–5.
72. Kentikelenis A, Karanikolos M, Williams G, et al. How do economic crises affect migrants’ risk of infectious disease? A systematic-narrative review. Eur J Public Health. 2015;25:937–944.10.1093/eurpub/ckv151
73. Zeitlmann N, George M, Falkenhorst G. Polio vaccination and stool screening in German reception centers for asylum seekers, November 2013–January 2014:what was implemented? Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016;59:584–591.10.1007/s00103-016-2334-7
74. ECDC. Infectious diseases of specific relevance to newly-arrived migrants in the EU/EEA. 2015.
75. Hahne S, Wormann T, Kretzschmar M. Migrants and hepatitis B:new strategies for secondary prevention needed. Eur J Public Health. 2009;19(4):439.10.1093/eurpub/ckp066
76. Merrett P, Schwartzman K, Rivest P, et al. Strategies to prevent varicella among newly arrived adult immigrants and refugees:a cost-effectiveness analysis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;44:1040–1048.10.1086/512673